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Surgical treatment of hemodialysis-related central
venous stenosis or occlusion: Another option to
maintain vascular access
Javier Eduardo Ferrari Ayarragaray, MD, Buenos Aires, Argentina
Background: The most common cause of graft failure in patients undergoing hemodialysis is outflow venous stenosis.
Long-term compromise of venous central trunks must be resolved.
Purpose: This study was undertaken to evaluate an unusual surgical option, bypass to decompress a long-term vascular
graft to the femoral vein, improving venous outflow, alleviating symptoms of venous hypertension, and restoring vascular
integrity for dialysis.
Patients and methods: The study included 3 patients with end-stage renal disease with signs and symptoms of dysfunc-
tioning grafts. Angiographic studies showed occlusion or stricture of the central venous tract and venous outflow
compromise. All patients had multiple temporary and long-term vascular access sites for hemodialysis, which were revised
several times. Venous decompression was performed with a bridge to the ipsilateral femoral vein. A 6 mm reinforced
polytetrafluoroethylene graft was tunneled subcutaneously along the thoracoabdominal wall. Patients were released 48
hours after the procedure, and periodic follow-up was carried out to detect changes in graft patency and function.
Results: There were no preoperative or intraoperative complications. Clear improvement in signs and symptoms of venous
hypertension were observed. Venous pressures decreased. Average follow-up was 16.3 months. In 1 patient the new graft
malfunctioned, and it was revised and repaired at 25 months. The presence of deep venous thrombosis and pulmonary
embolism required peritoneal dialysis. Two other patients, with no change in graft patency, died of concomitant disease.
Conclusion: Decompression of the femoral vein enables preservation of vascular graft patency and improves symptoms of
venous hypertension. (J Vasc Surg 2003;37:1043-6.)
The steadily increasing number of patients receiving
dialysis and longer life expectancy have resulted in more
patients in whom preservation of vascular access is a funda-
mental objective. Indiscriminate use of temporary access
catheters and lack of an adequate preoperative strategy to
select an appropriate access site lead to greater rates of
thrombosis and stenosis in the central venous trunk. Com-
promise of the axillosubclavian, jugular, or innominate vein
is a complication frequently observed over the long term.
Retrograde venous flow and venous hypertension predis-
pose to thrombosis of the vascular access site and render the
extremity useless.
Although percutaneous techniques and endovascular
stent placement have resolved difficult situations with fa-
vorable results, it is not possible to use these methods in all
patients.
The limited availability of access sites obliges the sur-
geon to seek alternatives to maintain permeability and
function of the arteriovenous fistula. Careful planning and
a rational sequence of procedural choices are often negated
because of comorbid conditions.
The purpose of the present study was to evaluate an
unusual surgical option in patients receiving hemodialysis
who have symptomatic upper extremity central venous
obstruction. Vascular access integrity may be restored with
decompression of the graft to the femoral vein, alleviating
symptoms of venous hypertension and minimizing late
sequelae.
PATIENTS AND METHODS
All patients included in the study agreed to the condi-
tions of the procedure by signing a consent form.
We examined 3 patients with end-stage renal disease
(ESRD) who were receiving maintenance hemodialysis,
with malfunctioning polytetrafluoroethylene (PTFE)
grafts, symptomatic upper extremity venous hypertension,
and ipsilateral arm-swelling edema. These patients had
multiple temporary and long-term vascular access sites,
which required surgical repair (eg, thrombectomy, anasto-
mosis revision, segmental graft resection) on several occa-
sions to maintain vascular patency (Table I).
In view of the symptoms and graft dysfunction, as
evidenced by increased arm-swelling edema, increased ve-
nous resistance (100 mm Hg; Fig 1), poor flow, and
elevated urea recirculation (15%), patients were evaluated
with color Doppler ultrasound scanning and angiography,
which reveal a segmental occlusion or severe stricture of the
central venous territory (jugular axillo-subclavian vein, in-
nominate vein, and superior vena cava (Fig 2, A, B, C). The
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endovascular approach was ruled out because of extension
and localization of the venous lesions, and use of the lower
extremities was contraindicated because of severe periph-
eral vascular disease (PVD) in all patients. Thus venous
decompression was performed with a bridge to the ipsilat-
eral femoral vein, with a 6 mm expanded and reinforced
PTFE graft (ATRIUM, Atrium Medical Corporation,
Hudson, NH).
With the patient under general anesthesia and having
undergone systemic intraoperative heparinization (1.5
mg/kg of weight), the brachioaxillary graft was approached
on the proximal edge. After proximal and distal control of
the graft was obtained, the vein was approached. An
oblique skin incision was made above the groin, and the
common ipsilateral femoral vein was dissected and exposed.
A reinforced 6 mm PTFE graft was tunneled subcutane-
ously with blunt dissection along the thoracoabdominal
wall, then sutured end-to-side with 6-0 prolene (Fig 3).
The patients were released 48 hours after the proce-
dure. Aspirin was administered as an antiplatelet agent.
Periodic follow-up w;ith clinical examination and venous
dialysis resistance determinations (Fig 1) were conducted
to detect changes in graft patency and function.
RESULTS
No intraoperative or perioperative complications were
associated with the procedure. All patients had clear im-
provement of symptoms, with reduction of swelling within
the first 48 to 72 hours. Venous pressure resistance de-
creased in all patients (Fig 1). Vascular access was easily
reached, enabling correct dialysis (300 mL/min.). At
average follow-up of 16.3 months, dysfunction of the new
arteriovenous graft was detected in 1 patient. Femoral
anastomosis revision was performed, and revealed a typical
perplastic subocclusive process. One month later deep ve-
nous thrombosis and pulmonary embolism developed, and
peritoneal dialysis was indicated.
The other 2 patients died of concomitant disease, with-
out changes in graft patency (Fig 1).
DISCUSSION
Central venous obstruction is difficult to manage and
resolve. In the absence of clinical symptoms it may go
unobserved, or mild arm edema may be premonitory.1
Elevated venous dialysis pressure is a sensitive indicator of
central venous obstruction.2 However, increasing venous
resistance may be largely ignored.
The rate of subclavian stenosis is considerable, al-
though symptoms appear in only 1% to 5% of cases.2-5 Pain
in the arm and massive edema, signs of ipsilateral venous
hypertension, result in marked disability of the extremity,
which is responsible for thrombosis of the access site and
inability to carry out proper dialysis. These drawbacks are
aggravated in patients requiring maintenance hemodialysis
for years, with multiple surgical interventions to revise the
access site. Successful thrombectomy and graft salvage rely
on reconstruction of the venous outflow tract, thereby
relieving symptoms and preserving vascular function.
When proximal vein thrombosis is complicated by a
functioning arteriovenous fistula, treatment options are
limited.
Conservative treatment of axillary and subclavian
thrombosis is usually palliative and ineffective.6 Because the
occlusion is probably related to repetitive intimal trauma or
infection, anticoagulant therapy, elevation of the extremity,
and manual lymphatic massage do not improve dialysis
results. Closure of the fistula is sometimes necessary, and
the arm is excluded for future vascular access.
Because of early restenosis and eventual recurrent per-
cutaneous intervention, transluminal dilation has demon-
strated few positive results compared with surgical treat-
ment.7-9 However, use of endovascular procedures has
improved rates of permeability when combined with stent
placement.10-16 Nonetheless, total occlusive lesions are still
difficult to resolve percutaneously.17,18
Table 1. Patient information
Patient Age (y) Sex Relevant history Symptoms and signs Site of obstruction Follow-up (mo)
1 65 Female Failed PTA; HTN; radical
mastectomy; severe PVD
Dialysis malfunction;
massive arm swelling
Innominate vein,
jugulosubclavian
junction
23
2 73 Male Failed PTA; severe PVD Arm swelling Axillo-subclavian vein 13
3 58 Male Severe PVD; diabetes; CHF Dialysis malfunction;
arm swelling
SVC, jugulosubclavian
junction
8
Graft patency
until death
PTA, Percutaneous transluminal angioplasty; HTN, hypertension; PVD, peripheral vascular disease; CHF, congestive heart failure; SVC, superior vena cava.
Fig 1. Venous pressure resistance before and after surgery.
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Several surgical approaches have been used to maxi-
mize the limited availability of access sites. The patency rate
of salvaged thrombosed PTFE dialysis grafts shows little
promise, particularly when thrombectomy alone is used.19
In most cases, complex revision is required, which usually
implies correction of venous outflow stenosis.20 Taking
into account cost-effectiveness, it is likely that a new graft
may be the best therapeutic option in some circumstanc-
es.19
Several tactics and techniques have been reported for
management of central vein thrombosis in an attempt to
avert sacrificing the fistula and improving symptoms of
venous hypertension. Transposition of the internal jugular
vein and anastomosis to axillary veins to provide venous
outflow was reported by Abud et al21 in 1992, and later
Puskas and Gertler22 published a case report detailing the
same technique. While the patient was readmitted at post-
operative month 3 with anastomotic stenosis, follow-up at
Fig 2. A, Patient 1. Venogram demostrates high-grade stenosis of left innominate vein (arrow). V.C.S., Superior vena
cava. B, Patient 2. Chronic catheter-related complete jugular and subclavian occlusion in a patient with painful
extremity edema and malfunctioning dialysis graft. C, Patient 3. Fistulogram demostrates tight stenosis at level of first
portion of subclavian vein over first rib.
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5 months revealed good vascular access after repair. In cases
of proximal thrombosis of the innominate vein, subclavian
to superior vena cava grafting can be performed, with a
horizontal sternal splitting incision (similar to the thymec-
tomy approach) to expose the proximal drainage.6 El-
Sabrout and Duncan23 and Duncan et al24 described right
atrial bypass grafting with the sternotomy approach. Al-
though this appears to be a procedure of greater magni-
tude, positive results and low morbidity were reported at
follow-up of 151⁄2 months. Another procedure that pro-
duces good results and may be considered a valid option is
extra-anatomic bypass to the external jugular vein, as re-
ported by Hansen et al25 in 1985.
In certain situations endovascular procedures cannot
be used to salvage malfunctioning access sites, or, if used,
may present difficulties. In our patients, use of venous
decompression of the femoral vein proved to be a simple
and safe procedure with low morbidity, enabling preserva-
tion of graft patency and improving symptoms of venous
hypertension.
We believe this technique may be a useful surgical
alternative in patients with multiple vascular access sites and
severe symptoms of stenosis or occlusion of the central
veins.
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Fig 3. Operative procedure. Schematic illustration of the bypass
graft from the braquial access to the femoral vein.
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